Capricor Therapeutics Inc
Change company Symbol lookup
Select an option...
CAPR Capricor Therapeutics Inc
PTTN Patten Energy Solutions Group Inc
MSFT Microsoft Corp
XOM Exxon Mobil Corp
CSCO Cisco Systems Inc
MRVL Marvell Technology Group Ltd
DHT DHT Holdings Inc
DLNG-A Dynagas LNG Partners LP
EEX Emerald Holding Inc
APEN Apollo Endosurgery Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the treatment of cardiovascular diseases, including orphan indications. Its product candidate, CAP-1002, a cardiosphere-derived cell product, is being tested in the ALLSTAR Phase II clinical study on patients having suffered a myocardial infarction (MI), while the DYNAMIC clinical study is testing CAP-1002 in patients in the advanced-stage of heart failure. CAP-1002 is also being tested in the HOPE-Duchenne Phase I/II clinical study for use in connection with Duchenne muscular dystrophy-related cardiomyopathy. Cenderitide, a dual receptor natriuretic peptide agonist, is being tested in a Phase II clinical study. Exosomes are nano-sized, membrane-enclosed vesicles.

Price
Delayed
$5.40
Day's Change
0.01 (0.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.74
Day's Low
5.39
Volume
(Light)

Today's volume of 813,520 shares is on pace to be much lighter than CAPR's 10-day average volume of 2,770,922 shares.

813,520

Upcoming Events

CAPR's fiscal year ends in December
There are no upcoming events for CAPR

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 14, 2020Q1 2020 Earnings Release-$0.30-$0.36 to -$0.30-$0.80
March 18, 2020Q4 2019 Earnings Release-$0.34-$0.44 to -$0.24-$1.10
November 7, 2019Q3 2019 Earnings Release-$0.43-$0.70 to -$0.70-$1.40
August 6, 2019Q2 2019 Earnings Release-$0.59-$0.80 to -$0.80-$1.40

Past Stock Splits

DateEvent description
June 5, 20191:10 Stock Split

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.